Top 20 of Fractures, Bone

Article title # Publications/# Citations

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

2002: Writing Group for the Women's Health Initiative Investigators; GLAnderson; SABeresford; BVHoward; RDJackson; KCJohnson; CKooperberg; JMKotchen; ... AZLaCroix; JOckene; RLPrentice; JERossouw; MLStefanick;

1331

Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation.

1969: WHHarris;

433

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

1998:

423

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

2001: CDArnaud; EFEriksen; GAGaich; HKGenant; ABHodsman; SIsh-Shalom; BHMitlak; RMNeer; ... RPrince; JYReginster; OWang; JRZanchetta;

319

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

2007: RBurge; BDawson-Hughes; AKing; DHSolomon; ATosteson; JBWong;

280

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

1996: DCBauer; DMBlack; JACauley; SRCummings; KEEnsrud; HKGenant; WLHaskell; DBKarpf; ... RMarcus; MCNevitt; SMOtt; SAQuandt; TFReiss; DEThompson; JCTorner;

275

Circulating mitochondrial DAMPs cause inflammatory responses to injury.

2010: KBrohi; YChen; CJHauser; KItagaki; WJunger; MRaoof; YSumi; TSursal; QZhang;

264

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

1994:

258

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

1996: OJohnell; DMarshall; HWedel;

238

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

2006: National Surgical Adjuvant Breast and Bowel Project (NSABP); JNAtkins; TBBevers; RSCecchini; JPCostantino; WMCronin; LFehrenbacher; LGFord; ... PAGanz; JJames; VCJordan; SMLippman; RGMargolese; WMcCaskill-Stevens; ERPajon; SEReis; ARobidoux; CDRunowicz; VGVogel; JLWade; DLWickerham; NWolmark;

228

Osteoporosis prevention, diagnosis, and therapy.

2001: NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy;

223

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.

1986: GAColditz; CHHennekens; PMartin; BRosner; LSampson; FESpeizer; MJStampfer; WCWillett;

218

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

2004: GABlock; GMChertow; PSKlassen; JMLazarus; EGLowrie; NOfsthun;

215

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

2007: HORIZON Pivotal Fracture Trial; DMBlack; SBoonen; JCaminis; JACauley; FCosman; SRCummings; PDDelmas; ... REastell; EFEriksen; HHu; TFHue; JKrasnow; PLakatos; PCLeung; ZMan; CMautalen; PMesenbrink; IRReid; TRosario-Jansen; DSellmeyer; KTong;

208

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

1999: DWAxelrod; JBrown; CHChesnut; EFEriksen; HKGenant; THangartner; STHarris; MSHoseyni; ... MKeller; CDMcKeever; PDMiller; NBWatts;

187

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

2005: EBarrett-Connor; JBBlank; JCauley; PMCawthon; SCummings; KEnsrud; CLewis; RMarcus; ... LMMarshall; JMcGowan; EOrwoll; KPhipps; SSherman; MLStefanick; KStone;

186

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

1998 Dec 23-30: WBApplegate; EBarrett-Connor; DMBlack; SRCummings; AZLaCroix; TAMusliner; LPalermo; RPrineas; ... SMRubin; JCScott; DEThompson; TVogt; RWallace; AJYates;

186

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

2005: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group; CACrowther; JEHiller; WSJeffries; AJMcPhee; JRMoss; JSRobinson;

183

Calcium plus vitamin D supplementation and the risk of fractures.

2006: Women's Health Initiative Investigators; GLAnderson; ARAssaf; DBarad; TBassford; SABeresford; HRBlack; PBlanchette; ... DEBonds; RLBrunner; RGBrzyski; BCaan; JACauley; RTChlebowski; SRCummings; MGass; IGranek; JHays; GHeiss; SLHendrix; BVHoward; JHsia; FAHubbell; RDJackson; KCJohnson; HJudd; JMKotchen; LHKuller; AZLaCroix; RDLanger; NLLasser; CELewis; MCLimacher; SLudlam; JEManson; KLMargolis; JMcGowan; MJO'Sullivan; JKOckene; LPhillips; RLPrentice; JRobbins; GESarto; MLStefanick; LVan Horn; JWactawski-Wende; RBWallace; EWhitlock;

176

Bone quality--the material and structural basis of bone strength and fragility.

2006: PDDelmas; ESeeman;

175